Apixaban: An effective treatment option for VTE
Venous thromboembolism (VTE) refers to deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE ranks among the top five most common vascular diseases in most countries. VTE is associated with a high risk of mortality (an estimated 20% of patients die within one year of diagnosis). Mortality is caused by either the VTE event or the disease/condition that provoked the event. Fortunately, VTE is preventable.